24
fair-value accounting under
IFRS
.
As a result, a total of 97 firms representing 96% of UK
firms in my sample used historical cost accounting with impairment testing under
IFRS
whereas only four firms representing 4% of UK firms in my sample used fair-value
accounting under
IFRS
.
In sum, Table C3 shows that when there was a choice between fair-value
accounting and historical cost accounting with impairment testing following the
mandatory adoption of
IFRS
, UK firms typically chose historical
cost accounting with
impairment testing. This finding is consistent with those of the Institute of Chartered
Accountants in England and Wales’ (ICAEW) 2007 report and Christensen and Nikolaev
(2010) that find most EU firms elected to use historical cost accounting with impairment
testing for
PPE
after
IFRS
adoption.
To test my second hypothesis (H2), I divide my total sample into two sub-
samples.
The first sub-sample of firms, which I label as
FV_HS
, consists of the 30 UK
firms (Table C3 – Panel B) that used fair-value accounting (
FV
) under UK GAAP and
then switched to historical cost accounting with strict impairment rules (
HS
) under
IFRS
.
The second sub-sample of firms, which I label as
HL_HS
, consists of the remaining 291
EU firms in my total sample that predominantly used historical cost accounting with
loose impairment rules (
HL
) under domestic GAAP and historical cost accounting with
strict impairment rules (
HS
) under
IFRS
.
28
I predict
that over-investment in
PPE
will be
lower for the two sub-samples following
IFRS
adoption (hypothesis 1), but the reduction
in over-investment will be greater among
FV_HS
firms
relative to
HL_HS
firms
(hypothesis 2).
28
As a robustness check, I also remove from this sub-sample the 4 UK firms that used fair-value
accounting under both UK GAAP and
IFRS
or switched from historical cost accounting with loose
impairment rules under UK GAAP to fair-value accounting under
IFRS
(Table C3 – Panel B). The results
(untabulated) are similar.